By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


DynPort Vaccine Company LLC 

60 Thomas Johnson Drive

Frederick  Maryland  21702  U.S.A.
Phone: 301-607-5000 Fax: 301-607-5099


Key Statistics

Ownership: Private

Web Site: DynPort Vaccine Company LLC



Company News
CSRA's DynPort Vaccine Company LLC To Help Advance Medical Products For The NIAID 12/27/2016 10:59:06 AM
AIBioTech Receives Subcontract Award From DynPort Vaccine Company LLC, for Continued Development and FDA Approval of a Nerve Agent Prophylactic 5/23/2013 9:33:02 AM
CSC's DynPort Vaccine Company LLC Wins $32.3 Million National Institute of Allergy And Infectious Diseases (NIAID) Contract to Establish Phase 1 Clinical Trial 7/14/2008 6:59:18 AM
DynPort Vaccine Company LLC to Continue Plague Vaccine Development 6/5/2008 9:00:55 AM
ImmuneRegen BioSciences, Inc. (IRBO) to Provide Adjuvant to DynPort Vaccine Company LLC for Development of an Inactivated Vaccine against Venezuelan Equine Encephalitis Virus 4/30/2008 9:23:48 AM
CSC's DVC And Baxter Begin Phase 1 Clinical Trial For Chemical Defense Product 1/18/2007 10:11:15 AM
Computer Sciences Corporation (CSC) And DynPort Vaccine Company LLC Announces FDA Approval Of Vaccinia Immune Globulin To Treat Adverse Reactions To Smallpox Vaccination10/19/2005 5:12:48 PM
U.S. Approves Treatment For DynPort Vaccine Company LLC's Smallpox Shot Reaction10/19/2005 5:12:47 PM
DynPort Vaccine Company LLC Announces FDA Acceptance For Filing Of Vaccinia Immune Globulin BLA10/19/2005 5:11:25 PM
Avant Immunotherapeutics (AVAN) Receives Additional Defense Contract For Clinical Testing Of Plague Component For Oral Anthrax/Plague Vaccine10/19/2005 5:10:59 PM